The rise of antimicrobial resistance (AMR) is often described as a "silent pandemic." As bacteria evolve to defeat the drugs designed to kill them, the healthcare industry is racing to develop new treatments, diagnostics, and preventive measures. This urgency has fueled significant growth in the Antibiotic Resistance Market, as governments and private sectors worldwide pour investment into...